Dive into the progress and challenges in Antibody-Drug Conjugates formulation and delivery for cancer treatment. We emphasize the advancements in targeting precision and efficacy, while discussing key development challenges like target selection, drug potency, and manufacturing complexities in this evolving oncology field.

Samsung Biologics will develop and manufacture drugs for Kurma’s portfolio companies, including by providing CMC drug development.

Before joining Amgen, Dr Tukra got his PhD from Purdue University in Industrial and Physical Pharmacy. While at Purdue he also worked at LyoHUB as an advisor and researcher in industrial and academic projects.

The pharmaceutical industry is increasingly looking for approaches to shorten drug development timelines and save on cost, especially virtual biotech companies who rely heavily on key milestone payments. It is therefore imperative that new chemical entities can be quickly manufactured quickly into clinical drug products.

Tailor-made pharmaceutical development & commercial solutions.

How Almac developed a flexible paediatric dosage form using a robust manufacturing and filling process suitable for routine commercial manufacture.

Specialising in solid oral dose formulations, 300,000ft² of drug product development footprint, multiple containment strategies for highly potent materials.

Aptar Pharma’s range of UDS (Unidose system) systems, particularly the UDS powder, is a proven, ready-to-use platform, providing a precise single dose via the nose quickly and easily.

CMC development support, characterisation, stability and quality control services.

Contract drug development expertise to accelerate your inhaled biomolecule to market.

To meet your development milestones and comply with regulatory requirements, you will need high quality bioanalytical and analytical data to aid informed decision-making and identify sources of risk.